Mercer Global Advisors’s Structure Therapeutics GPCR Stock Holding History

Mercer Global Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.22K	Buy	+60	New	+$2.65K	﹤0.01%	5478

Other funds holding GPCR

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CLGM

Capitolis Liquid Global Markets New York $23B AUM 48.97% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Davern Capital Partners Ny, New York $587M AUM

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Mercer Global Advisors's GPCR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 60 shares worth $3.22K. The stake represents ﹤0.01% of the portfolio and ranks #5478 among its holdings.

110 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Mercer Global Advisors held 60 shares of Structure Therapeutics worth $3.22K as of Q2 2026.
Structure Therapeutics was a new Mercer Global Advisors position in Q2 2026.
Structure Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5478 holding.
110 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.